Iodine-131 Isotope Market - Global Forecast 2026-2032

The Iodine-131 Isotope Market is transforming as healthcare systems prioritize advanced radiopharmaceutical applications, robust supply frameworks, and stringent regulatory alignment. Senior leaders navigating this sector must integrate multidisciplinary perspectives to ensure strategic resource allocation and sustained operational excellence.

Market Snapshot: Iodine-131 Isotope Market Size and Growth Outlook

The Iodine-131 Isotope Market grew from USD 745.30 million in 2025 to USD 788.67 million in 2026. Projected to maintain a 5.47% CAGR, it is expected to reach USD 1.08 billion by 2032. Expansion is driven by heightened clinical requirements, regulatory recalibration, and evolving supply-channel structures. These trends reflect how healthcare organizations and suppliers are adapting to policy shifts, technological updates, and changing clinical protocols to meet rising demand and efficiency goals.

Iodine-131 Clinical Roles and Strategic Market Scope

Iodine-131 remains central to diagnostic and therapeutic strategies across cancer care, thyroid intervention, and complex medical imaging. This report delivers a complete breakdown of innovation trends, product types, regulatory interactions, and distribution approaches shaping market trajectory. Leaders gain a precise understanding of key operational domains, technology deployments, and regional factors crucial to outcome optimization.

Application Areas: Encompasses cancer therapy, including targeted regimens and combination protocols, thyroid ablation treatments, and both routine and specialized imaging procedures.
Product Formats: Includes capsules for streamlined outpatient care, injectable solutions such as prefilled syringes and vials for adaptable dosing, and liquid preparations suitable for on-site customization at point of care.
End-Use Settings: Relevant environments include hospitals, diagnostic centers, ambulatory clinics, and research institutes, each demanding tailored support, supply scale, and technical guidance.
Distribution Models: Models span direct procurement for large health systems and wider distributor networks to address smaller or geographically spread facilities.
Regional Coverage: The market spans the Americas, Europe, Middle East and Africa, and Asia-Pacific, reflecting distinctive regional supply infrastructures, regulatory climates, and production capabilities.
Technology Integration: Features such as dose-on-demand manufacturing, automated dispensing, enhanced cold-chain management, and logistics optimization are reshaping delivery and efficiency across facilities.

Iodine-131 Isotope Market: Key Takeaways for Decision-Makers

Stakeholders are placing greater emphasis on cross-functional coordination in isotope sourcing, assessing clinical impact, procurement vulnerabilities, and compliance across departments.
Radiochemistry advancements and workflow automation are directly influencing therapeutic precision, optimizing patient scheduling, and reducing radioactive waste management costs.
Intensified regulatory scrutiny regarding traceability, safety, and ecological impact is prompting expanded investment in local production and digitally secure supply routes.
Integrated service offerings—combining supply management, regulatory consulting, and technical troubleshooting—have become key differentiators for suppliers during competitive procurement cycles.
Regional variation in end-use protocols and compliance standards yields a spectrum of product format choices, tendering approaches, and bespoke logistical solutions tailored to specific healthcare environments.

Tariff Impact on Sourcing and Service Continuity

Recent tariffs and trade adjustments introduced in 2025 have amplified challenges in managing the iodine-131 supply chain. Manufacturers and distributors are increasingly relying on local production strategies and establishing longer-term bilateral agreements. These measures support continued service delivery despite global market fluctuations. Healthcare facilities are likewise adjusting procurement intervals and modifying inventory policies to offset cost variables and leverage available exemptions.

Methodology & Data Sources

Insights presented stem from structured interviews with clinical specialists, operational leaders, and regulatory authorities. The research further draws on targeted reviews of technical and legal documentation, complemented by cross-checks with manufacturers and supply-chain partners. Risk analyses and responsible data anonymization practices support actionable guidance and sector reliability.

Why This Report Matters for Senior Leaders

Clarifies how convergence of new technologies, shifting policy frameworks, and trade actions reshape both immediate and long-term isotopic product strategies for provider organizations and suppliers.
Enables multi-faceted analysis, aligning clinical objectives, sourcing strategies, and contracting options with evolving business priorities and compliance standards.
Supports resilience-building with recommendations for workforce strategy and regulatory engagement, relevant for organizations operating or expanding in high-potential areas worldwide.

Conclusion

The Iodine-131 Isotope Market is best navigated through integrated leadership, blending regulatory vigilance, technology adoption, and supply-chain foresight. Organizations adopting this approach are better positioned to sustain care quality and operational reliability as the industry landscape advances.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Iodine-131 Isotope Market, by Product Type

8.1. Capsule
8.2. Injectable
8.2.1. Prefilled Syringe
8.2.2. Vial
8.3. Liquid Solution

9. Iodine-131 Isotope Market, by Application

9.1. Cancer Therapy
9.1.1. Combination Therapy
9.1.2. Targeted Therapy
9.2. Medical Imaging
9.3. Thyroid Treatment

10. Iodine-131 Isotope Market, by End Use

10.1. Diagnostic Centers
10.2. Hospitals
10.3. Research Institutes

11. Iodine-131 Isotope Market, by Distribution Channel

11.1. Direct Sales
11.2. Distributors

12. Iodine-131 Isotope Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Iodine-131 Isotope Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Iodine-131 Isotope Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Iodine-131 Isotope Market
16. China Iodine-131 Isotope Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Advanced Accelerator Applications S.A.
17.6. China Isotope & Radiation Corporation
17.7. Curium Pharma SAS
17.8. Eckert & Ziegler Radiopharma GmbH
17.9. Institute for Radioelements SCRL
17.10. Jubilant Pharma Limited
17.11. Lantheus Holdings, Inc.
17.12. Mallinckrodt plc
17.13. Nordion Inc.
17.14. NorthStar Medical Radioisotopes LLC
17.15. NorthStar Medical Radioisotopes LLC

List of Figures

FIGURE 1. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IODINE-131 ISOTOPE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IODINE-131 ISOTOPE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 87. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 99. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 101. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 102. AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 114. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 116. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 117. ASEAN IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. GCC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GCC IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. GCC IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 121. GCC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. GCC IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 123. GCC IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 124. GCC IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 135. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 137. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 138. BRICS IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. G7 IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. G7 IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. G7 IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 142. G7 IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. G7 IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 144. G7 IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 145. G7 IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 146. NATO IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. NATO IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. NATO IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 149. NATO IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. NATO IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 151. NATO IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 152. NATO IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. CHINA IODINE-131 ISOTOPE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 162. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 164. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY CANCER THERAPY, 2018-2032 (USD MILLION)
TABLE 166. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 167. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

Advanced Accelerator Applications S.A.
China Isotope & Radiation Corporation
Curium Pharma SAS
Eckert & Ziegler Radiopharma GmbH
Institute for Radioelements SCRL
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Mallinckrodt plc
Nordion Inc.
NorthStar Medical Radioisotopes LLC
NorthStar Medical Radioisotopes LLC

Table Information

Report Attribute	Details
No. of Pages	193
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 788.67 Million
Forecasted Market Value ( USD ) by 2032	$ 1080 Million
Compound Annual Growth Rate	5.4%
Regions Covered	Global
No. of Companies Mentioned	11

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Iodine-131 Isotope Market Size and Growth Outlook

Iodine-131 Clinical Roles and Strategic Market Scope

Iodine-131 Isotope Market: Key Takeaways for Decision-Makers

Tariff Impact on Sourcing and Service Continuity

Methodology & Data Sources

Why This Report Matters for Senior Leaders

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Iodine Radioisotope Market - Global Forecast 2025-2030

Medical Radioactive Iodine I-131 Market - Global Forecast 2025-2030

Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

Iodine-125 (I-125) Sealed Seed Source Market Report: Trends, Forecast and Competitive Analysis to 2031

Iodine Market Report 2025